COF:NYSECapital One Financial Corporation Analysis
Data as of 2026-05-27 - not real-time
$186.42
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Capital One is trading at $186.42, which sits below its 20‑day ($188.03) and 50‑day ($188.96) simple moving averages, signaling a short‑term bearish bias. The RSI of 46 is neutral, while the MACD line remains negative but just above its signal line, producing a modest bullish histogram – a mixed technical picture that leans toward caution. The stock finds immediate support near $180 and faces resistance around $196, with volume remaining stable despite a 30‑day volatility of 24.7% and a beta of 1.48, underscoring heightened market sensitivity. Fundamentally, the trailing P/E of 57.5 dwarfs the industry average of 16.7, suggesting current pricing is stretched. However, the forward P/E of 7.7 and a DCF‑derived fair value implying a 36.9% upside paint a more optimistic outlook. Revenue growth of 46% and a forward EPS projection of $24.29 indicate strong earnings momentum, yet the dividend payout ratio of 86% raises questions about sustainability, a concern echoed in recent dividend‑timeline news. Analyst sentiment is split: while a “buy” consensus and a notable investor (Steve Cohen) highlight upside potential, cautionary commentary on dividend durability tempers enthusiasm. Recent strategic moves, such as the announced acquisition of Discover Financial and fintech expansion, could unlock further growth if integration succeeds. Overall, the stock sits at a crossroads between technical weakness and compelling forward fundamentals, making the near‑term outlook nuanced.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages
- High near‑term volatility and beta
- Dividend payout ratio near 86%
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings growth and low forward P/E
- Resistance level at $196 offering upside
- Strategic acquisitions expanding payments footprint
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑derived fair value indicating ~37% upside
- Sustained revenue growth and fintech transformation
- Broad analyst consensus with a “buy” recommendation
Key Metrics & Analysis
Financial Health
Revenue Growth46.30%
Profit Margin8.88%
P/E Ratio57.5
ROE3.26%
ROA0.49%
P/B Ratio1.1
Op. Cash Flow$29.1B
Industry P/E16.7
Technical Analysis
TrendBearish
RSI46.1
Support$180.00
Resistance$196.00
MA 20$188.03
MA 50$188.96
MA 200$212.32
MACDBullish
VolumeStable
Fear & Greed Index91.11
Valuation
Fair Value$1,202.83
Target Price$255.19
Upside/Downside36.89%
GradeFair
TypeBlend
Dividend Yield1.72%
Risk Assessment
Beta1.48
Volatility24.73%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.